|
|
 |
|
Viewing report
|
|
|
|
Lung Cancer, 3rd Edition
John Wiley and Sons Ltd, Jan 2008, Pages: 480
Lung cancer is a major cause of cancer-related deaths in men and women. However, since the first edition of Lung Cancer was published 14 years ago, rapid progress in the biology, prevention, diagnosis, and treatment of the disease has been made.
Authors bio:
Jack A. Roth, MD FACS, Professor and Chairman, Bud Johnson Clinical Distinguished Chair, The University of Texas M.D. Anderson Cancer Center, Department of Thoracic & Cardiovascular Surgery and Professor of Molecular and Cellular Oncology, Director, W.M. Keck Center for Cancer Gene Therapy, Houston, Texas, USA.
James D. Cox, MD, Professor and Head, Division of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Waun Ki Hong, MD, American Cancer Society Clinical Research Professor, Charles A. LeMistre Distinguished Chair in Thoracic Oncology and Professor and Chairman, Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Customers who bought this item also bought
Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities
Lung Cancer, 3rd Edition
Drug Targets for Breast Cancer
25+ Business Development and Innovation Opportunities in Cancer Medicine - 2001
Introduction to the Cellular and Molecular Biology of Cancer, Fourth Edition
Cancer Drug Discoveries: What the Future Holds
Cancer Therapeutics Markets
Cancer Drug Discoveries: What the Future Holds: Non-Small Cell Lung Cancer Chapter
|
|
|
|
